| 注册
首页|期刊导航|中国医学创新|影响经皮冠状动脉介入治疗冠心病后复发的危险因素分析

影响经皮冠状动脉介入治疗冠心病后复发的危险因素分析

刘曙杰

中国医学创新Issue(29):108-110,111,4.
中国医学创新Issue(29):108-110,111,4.DOI:10.3969/j.issn.1674-4985.2014.29.039

影响经皮冠状动脉介入治疗冠心病后复发的危险因素分析

Recrudescence Risk Factors Analysis of Percutaneous Coronary Intervention in Patients with Coronary Heart Disease

刘曙杰1

作者信息

  • 1. 山东省青岛市城阳区人民医院 山东 青岛 266109
  • 折叠

摘要

Abstract

Objective:To explore recrudescence risk factors analysis of percutaneous coronary intervention in patients with coronary heart disease. Method:125 patients with coronary heart disease treated by percutaneous coronary intervention from May 2011 to February 2014 were selected and 120 patients were in because of 5 patients lost of follow up. Their medical records,regular telephone follow-up after operation and discharge and periodically review data were collected and arranged,including their basic information,mode of life,depression evaluation and survival data. Result:Patients with hypertension history,exercise time less than 30 min every day,diabetes mellitus history,heavy depression had higher 1 year recurrence rate(P<0.05). Hypertension history,exercise time less than 30 min every day,diabetes mellitus history,heavy depression were risk factors of percutaneous coronary intervention in patients with coronary heart disease and hypertension history had the maximum degree of risk(OR=3.575, 95%CI=1.446-8.842). The criticality of other risk factors from high to low were exercise time less than 30 min every day (OR=3.347,95%CI=1.424-7.866),heavy depression(OR=2.824,95%CI=1.578-5.054),diabetes mellitus history (OR=2.356,95%CI=1.246-4.455). Conclusion:Hypertension history,exercise time less than 30 min every day, diabetes mellitus history,heavy depression are risk factors of percutaneous coronary intervention in patients with coronary heart disease.

关键词

经皮冠状动脉介入治疗/冠心病/复发/危险因素

Key words

Percutaneous coronary intervention/Coronary heart disease/Recrudescence/Risk factors

引用本文复制引用

刘曙杰..影响经皮冠状动脉介入治疗冠心病后复发的危险因素分析[J].中国医学创新,2014,(29):108-110,111,4.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文